Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 3Neoplasms 3Malnutrition 3Lung Neoplasms 3Diarrhea 3Mucositis 2Enteritis 2Chalazion 2Carcinoma, Hepatocellular 2Thyroid Neoplasms 1Squamous Intraepithelial Lesions 1Smoldering Multiple Myeloma 1Psychological Well-Being 1Polycystic Ovary Syndrome 1Periampullary Carcinoma Nos 1Pelvic Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Neoplasms, Second Primary 1Muscle Invasive Bladder Cancer (MIBC) 1Multiple Myeloma 1Motor Activity 1Monoclonal Gammopathy of Undetermined Significance 1Liver Cirrhosis 1Limited Stage Small Cell Lung Cancer 1Laryngeal Neoplasms 1Inflammation 1Infections 1

Interventions

testosterone undecanoate 1Valganciclovir 1Therapeutic Touch 1TES 1Procalcitonin 1Probiotics 1Etanercept 1Drug Evaluation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Fatigue Syndrome, Chronic × Probiotics × Clear all
NCT03773003 2025-05-29

IMPROFA

Universität des Saarlandes

Phase NA Recruiting
150 enrolled

Fatigue Syndrome, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡